Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00722
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Targeting the Pim Kinases in Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2015English

IL-3 Is a Novel Target to Interfere With Tumor Vasculature

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Multiple Myeloma-Associated AL Amyloidosis: Is a Distinctive Therapeutic Approach Warranted?

Bone Marrow Transplantation
TransplantationHematology
2006English

Novel Antiangiogenic Molecules in Multiple Myeloma

2012English

Therapeutic Targeting of N-Cadherin Is an Effective Treatment for Multiple Myeloma

British Journal of Haematology
Hematology
2015English

Targeting the Phosphatidylinositol 3-Kinase Pathway in Multiple Myeloma

Clinical Cancer Research
Cancer ResearchOncology
2007English

Novel Strategies to Target the Ubiquitin Proteasome System in Multiple Myeloma

Oncotarget
Oncology
2015English

The Therapeutic Potential of Cell Cycle Targeting in Multiple Myeloma

Oncotarget
Oncology
2017English

Response to Dexamethasone Is Glucose-Sensitive in Multiple Myeloma Cell Lines

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy